Newscast – Page 85 – media

Healthcare startups take on the challenge of improving medical equipment delivery, tracking

When Parachute Health founder and CEO David Gelbard’s father was discharged from the hospital following spine surgery, the hospital ordered a walker to assist him as he recovered. But for weeks, it didn’t arrive and Gelbard’s father subsequently fell, adding years to his rehabilitation.
- Source: MedCityNews
- 502
- April 24, 2018
Company Insights medical device products
How health apps factor into a $950B ecosystem

Highlighting the ubiquity and importance of smartphones across multiple industries, a new report by ACT | The App Association indicated that two out of three businesses utilize enterprise apps. And many of those opportunities are rising up throughout the healthcare industry.
- Source: Fierce Healthcare
- 636
- April 24, 2018
healthcare Market Views mHealth
Novartis pads case for new MS blockbuster with disease-progression analysis

Novartis is hoping multiple sclerosis candidate siponimod’s performance in secondary progressive patients can help it secure a blockbuster approval. And now it has more data to put toward that case.
- Source: fiercepharma
- 543
- April 23, 2018
blockbuster Company Insight multiple sclerosis
Allergan swoops in as Takeda’s third Shire bid falls short at $61B

Three of Takeda’s anticipated Shire buyout bids have already been rejected—and now, the Japanese drugmaker might just lose out to a competing bidder. Allergan, for instance, is already in talks for a buy.
- Source: fiercepharma
- 511
- April 23, 2018
drugmaker Market Views
Bristol-Myers Squibb Announces Worldwide Collaboration with Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

Factor XIa inhibitor moving into Phase 2 Trials for Secondary Stroke Prevention Bristol-Myers Squibb to receive upfront payment and companies to share development and commercialization costs, and global profits
- Source: news.bms
- 608
- April 23, 2018
Bristol-Myers Squibb Cardiovascular Therapy Janssen
Merck KGaA, not Pfizer, lands consumer health deal with P&G worth $4.2B

Merck KGaA will hand P&G a consumer business that has grown 6% over the past two years. (Merck KGaA) Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.
- Source: fiercepharma
- 3,305
- April 23, 2018
Company Insight consumer business Merck
Is mHealth Monitoring for Hypertension Safer Than the Doctor’s Office?

A recent study of so-called 'white coat hypertension' finds that blood pressure readings taken at the doctor's office can be less accurate and more dangerous than readings taken at home with mHealth devices.
- Source: mHealthIntelligence
- 1,272
- April 23, 2018
hypertension mHealth Researches
RapidSOS collects $16M to deliver stronger data to emergency response teams

RapidSOS, a five-year-old startup focused on updating emergency response systems with data-driven technology, has raised $16 million in funding from Highland Capital, Microsoft Ventures, and CSAA Insurance Group, according to a statement. Forté Ventures also contributed.
- Source: MobiHealthNews
- 465
- April 23, 2018
Company Insights digital health healthcare
The 3 most valuable applications of AI in health care

A recent report from Accenture analyzed the “near-term value” of AI applications in health care to determine how the potential impact of the technology stacks up against the upfront costs of implementation. Results from the report estimated that AI applications in health care could save up to $150 billion annually for the U.S. health care economy by 2026.
- Source: Venture Beats
- 700
- April 23, 2018
AI digital health Market Views
Amid tough respiratory competition, AstraZeneca inks Symbicort outcomes-based deals

It's no secret that respiratory drugs make up a crowded field, and forthcoming generics will make the competition tougher still. AstraZeneca's Symbicort is no stranger to the fallout, either, what with payers pressing prices and new rivals grabbing share.
- Source: fiercepharma
- 635
- April 20, 2018
AstraZeneca Company Insights Symbicor

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.